share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

SEC announcement ·  Apr 27 01:28
Summary by Futu AI
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on Narayen's holdings and the overall market position of Pfizer remains unclear.
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on Narayen's holdings and the overall market position of Pfizer remains unclear.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.